Commercial terms and exact-model provenance remain subject to current source checks.
Reader service card
Practice ownership and buying signals
OwnershipNo reader benchmark yet
EvaluationNo reader benchmark yet
Replacement intentNo reader benchmark yet
SponsorNo sponsor
Device Pulse is not collecting these actions on this page. Disabled controls show the planned reader service without creating a response, lead, sponsor relationship, or vendor request.
Activation requires a separate consent notice, controlled storage, duplicate and suppression rules, retention and deletion controls, named vendor-transfer disclosure, and an audit log. Newsletter signup does not activate these controls.
Overview
Clear + Brilliant Touch is a Solta Medical platform in the skin resurfacing category. The manufacturer describes it as using Fractional non-ablative 1440 nm and 1927 nm diode laser handpieces for face, neck, chest, hands. Those specifications are company-reported, not an independent performance conclusion.
The 1440 nm and 1927 nm handpieces are cleared for dermatological soft-tissue coagulation and general skin resurfacing. Consumer appearance claims are company-reported and should not be treated as comparative evidence. The cited FDA records establish only the device names, classifications, or indications stated in those records. They do not establish comparative superiority, outcomes for every patient, or current commercial terms.
Before purchase, request the exact model, cleared indications, software version, handpieces, service coverage, training, and a written quote. Pricing and operating economics remain unknown where a current source packet was not available.
TREATMENT AREAS
Face, Neck, Chest, Hands
TREATMENT TIME
Manufacturer does not publish one universal treatment time
SESSIONS
Individualized treatment series; no universal protocol established here
PER SESSION
Practice-set; no verified range
CONSUMABLES/YR
Treatment-credit and tip costs require a current quote
MAINTENANCE/YR
Service quote required
Pros & Cons
Pros
Two wavelength options support different superficial resurfacing workflows
FDA summary identifies the handpieces and intended use
The system is positioned for lower-intensity resurfacing workflows
Solta publishes an operator manual and current safety information
Cons
Public pricing and treatment-credit economics were not reconciled
The FDA indication does not prove superiority over other resurfacing lasers
Pigment change, prolonged redness, burns, and scarring remain possible laser risks
Buyers need the exact console, handpiece, credit-key, and service configuration in writing
Clinical Evidence
FDA summaries document substantial-equivalence testing and intended use. Device Pulse has not yet reconciled a current independent head-to-head clinical evidence table for this profile.
This profile does not treat a clearance record or manufacturer page as proof of superior outcomes. Match each clinical claim to the exact model, indication, study design, sample size, source date, and funding disclosure.
The current packet supports product identification and the limited regulatory statements shown here. Independent comparative effectiveness, local demand, and practice economics remain open diligence questions.
ROI Analysis
Device Pulse is not publishing a payback estimate for Clear + Brilliant Touch because current transaction price, financing, service, consumables, staffing, and local patient demand have not been independently verified.
Build the decision from your written quote. Model conservative monthly treatment volume, realized revenue per treatment, consumables, operator time, service, downtime, financing, and patient-acquisition cost. Run a downside case before using the model in a purchase decision.
A manufacturer projection is an input to test, not a forecast. Ask for every assumption in writing and compare it with your scheduling capacity and historical conversion data.
Best For
Dermatology and aesthetic practices comparing a lower-intensity fractional resurfacing option and willing to verify treatment-credit economics and exact handpiece configuration before purchase.
Use that as a short-list hypothesis. Confirm the exact indication, patient mix, operator training, local service, workflow, and written commercial terms before deciding that the platform fits the practice.
Buying Guide
Request a written, model-specific quote for Clear + Brilliant Touch. Separate the console, handpieces, software, training, installation, warranty, service, and recurring supplies or licensing.
Confirm the serial number, current software, cleared indications, ownership-transfer terms, parts availability, response time, and local service provider. Do not assume a product-page feature applies to every configuration.
Ask Solta Medical to identify which statements are specifications, which are company-reported claims, and which are supported by independent clinical evidence. Keep those records with the final contract.
Alternatives to review
Use these profiles to build a short list. An alternative listing is not a claim of equivalence or superiority.
MOXI: Dermatology and aesthetic practices comparing a lower-intensity 1927 nm resurfacing workflow and willing to verify tip costs, current labeling, training, and co
NEW Manufacturer quote required · USED No reconciled dated sample
LaseMD Ultra: Med spas and dermatology practices that want a low-downtime resurfacing option at a reasonable capital cost. Practices that can package ampoule add-ons into per
Fraxel Dual: Dermatology practices that treat melasma and photodamaged skin on mixed patient populations. Practices that value brand recognition and a deep evidence base.
Halo: High-end dermatology and plastic surgery practices with an established skin resurfacing patient base. Practices that already own or plan to build the Sciton Jou
NEW $145,000-$210,000 (as Joule module) · USED $80,000-$140,000
A current acquisition price was not published in the reviewed source packet. Request a written quote from Solta Medical that separates the console, handpieces, software, training, installation, warranty, service, and recurring supplies.
What is the FDA status of Clear + Brilliant Touch?
FDA 510(k) K223647 covers the Clear + Brilliant Touch laser system with 1440 nm and 1927 nm handpieces for soft-tissue coagulation and general skin resurfacing.
What evidence supports this Clear + Brilliant Touch profile?
FDA summaries document substantial-equivalence testing and intended use. Device Pulse has not yet reconciled a current independent head-to-head clinical evidence table for this profile. The source packet separates FDA public records from manufacturer-reported product information. It does not establish comparative superiority.
Which practices should evaluate Clear + Brilliant Touch?
Dermatology and aesthetic practices comparing a lower-intensity fractional resurfacing option and willing to verify treatment-credit economics and exact handpiece configuration before purchase. That is an editorial fit question, not a clinical or financial conclusion.
What should a buyer verify before ordering Clear + Brilliant Touch?
Verify the exact model, cleared indications, handpieces, software, serial-number history, training, service response, warranty, ownership-transfer terms, recurring supplies, and every commercial assumption in writing.
What are the main limitations in this Clear + Brilliant Touch profile?
Current limitations include: Public pricing and treatment-credit economics were not reconciled; The FDA indication does not prove superiority over other resurfacing lasers; Pigment change, prolonged redness, burns, and scarring remain possible laser risks. Recheck the dated primary sources before using the profile in a purchase decision.
Get the Device Quote Review Kit
Open the printable buyer checklist now, then get the planned Tuesday brief with price, FDA, safety, evidence, and manufacturer signals.
Free kit available immediately. Planned Tuesday brief. Unsubscribe anytime. Privacy.
